Cargando…

Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study

INTRODUCTION: Kidney transplantation is the optimal treatment in end-stage kidney disease, but de-novo donor specific antibody development continues to negatively impact patients undergoing kidney transplantation. One of the recent advances in solid organ transplantation has been the definition of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemieux, William, Fleischer, David, Yang, Archer Yi, Niemann, Matthias, Oualkacha, Karim, Klement, William, Richard, Lucie, Polychronakos, Constantin, Liwski, Robert, Claas, Frans, Gebel, Howard M., Keown, Paul A., Lewin, Antoine, Sapir-Pichhadze, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730505/ https://www.ncbi.nlm.nih.gov/pubmed/36505483 http://dx.doi.org/10.3389/fimmu.2022.1067075

Ejemplares similares

On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss
por: Mohammadhassanzadeh, Hossein, et al.
Publicado: (2021)

Performance of an allele‐level multi‐locus HLA genotype imputation tool in hematopoietic stem cell donors from Quebec
por: Ferradji, Abdelhakim, et al.
Publicado: (2017)

Abstract 28 Comparative Analysis of the Cord Blood Bank in Quebec
por: Lemieux, William, et al.
Publicado: (2022)

High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation
por: Tran, Jenny N., et al.
Publicado: (2021)

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression
por: Israeli, Moshe, et al.
Publicado: (2014)

Clinical application of immune repertoire sequencing in solid organ transplant
por: Wong, Paaksum, et al.
Publicado: (2023)

Policy Challenges for Organ Allocation in an Era of “Precision Medicine”
por: Caulfield, Timothy, et al.
Publicado: (2020)

Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online public deliberation
por: Slomp, Caitlin, et al.
Publicado: (2023)

Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival
por: Bekbolsynov, Dulat, et al.
Publicado: (2020)

HLA antibody testing: a tool to facilitate not to prevent organ transplantation
por: Claas, Frans H J
Publicado: (2008)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors
por: Lemieux, William, et al.
Publicado: (2023)

Molecular‐level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients – a retrospective study
por: Osorio‐Jaramillo, Emilio, et al.
Publicado: (2020)

Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches
por: Kunze-Schumacher, Heike, et al.
Publicado: (2014)

A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity
por: Wiebe, Chris, et al.
Publicado: (2018)

Adding epitope compatibility to deceased donor kidney allocation criteria: recommendations from a pan-Canadian online public deliberation
por: Edwards, Louisa, et al.
Publicado: (2023)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
por: Bacigalupo, Andrea, et al.
Publicado: (2016)

Novel alleles in the era of next-generation sequencing-based HLA typing calls for standardization and policy
por: Tran, Jenny N., et al.
Publicado: (2023)

Congenital Cytomegalovirus Infection: Maternal–Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome
por: Rovito, Roberta, et al.
Publicado: (2018)

Abstract 25 ECTmatch: Optimizing Small-Scale Cord Blood Banking Through HLA Analysis
por: Dumont-Lagacé, Maude, et al.
Publicado: (2022)

Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation
por: Meurer, Thuja, et al.
Publicado: (2018)

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2021)

Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine
por: Maier, Mirela, et al.
Publicado: (2017)

T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity
por: Lum, Su Han, et al.
Publicado: (2022)

Towards uniformity in the definition of acceptable mismatches for highly sensitized patients
por: Chen, Mian, et al.
Publicado: (2019)

HLA‐EMMA: A user‐friendly tool to analyse HLA class I and class II compatibility on the amino acid level
por: Kramer, Cynthia S. M., et al.
Publicado: (2020)

Novel insights into non‐HLA alloimmunity in kidney transplantation
por: Reindl‐Schwaighofer, Roman, et al.
Publicado: (2019)

Allorecognition of HLA-C Mismatches by CD8(+) T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities
por: Bettens, Florence, et al.
Publicado: (2016)

HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors
por: Pession, Andrea, et al.
Publicado: (2011)

Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome
por: Thus, Kirsten A., et al.
Publicado: (2014)

HLA Mismatching Strategies for Solid Organ Transplantation – A Balancing Act
por: Zachary, Andrea A., et al.
Publicado: (2016)

Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage
por: Chopera, Denis R., et al.
Publicado: (2008)

Editorial: Future challenges and directions in determining allo-immunity in kidney transplantation
por: Lim, Wai H., et al.
Publicado: (2022)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
por: Jucaud, Vadim
Publicado: (2017)

Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches
por: Heidt, Sebastiaan, et al.
Publicado: (2021)

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
por: Wiebe, Chris, et al.
Publicado: (2018)

HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients
por: Xu, Ruonan, et al.
Publicado: (2021)

Peptides Derived From Mismatched Paternal Human Leukocyte Antigen Predicted to Be Presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP Induce Child-Specific Antibodies in Pregnant Women
por: Niemann, Matthias, et al.
Publicado: (2021)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tbeh622mva2v1j7qjr2rcitti1